Prestige Consumer Healthcare (PBH) Debt Ratio (2011 - 2024)
Prestige Consumer Healthcare (PBH) recorded quarterly Debt Ratio of 0.34 in Q1 2024, down 15.46% quarter-over-quarter from 0.4 in Q1 2023, and down 15.46% on a YoY basis from 0.4 in Q2 2023.
Prestige Consumer Healthcare (PBH) Debt Ratio (2011 - 2024) Analysis & Trends
Prestige Consumer Healthcare's Debt Ratio history runs 14 years deep, the most recent figure standing at 0.34 for Q1 2024.
- In Q1 2024, Debt Ratio fell 15.46% year-over-year to 0.34; the TTM figure through Mar 2024 stood at 0.34 (down 15.46% YoY), while the FY2024 annual figure was 0.34, down 15.46% from the prior year.
- Debt Ratio was 0.34 for Q1 2024 at Prestige Consumer Healthcare, down from 0.4 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.49 in Q1 2020 to a low of 0.0 in Q3 2021.
- Historically, Debt Ratio has averaged 0.39 across 5 years, with a median of 0.43 in 2021.
- The sharpest annual moves came in 2021 and 2023: Debt Ratio slumped 99.64% in 2021, then retreated 0.25% in 2023.
- A 5-year view of Debt Ratio shows it stood at 0.45 in 2020, then plunged by 99.63% to 0.0 in 2021, then surged by 24545.41% to 0.4 in 2022, then slipped by 0.25% to 0.4 in 2023, then dropped by 15.46% to 0.34 in 2024.
- The last three Debt Ratio figures came in at 0.34 (Q1 2024), 0.4 (Q1 2023), and 0.4 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.42 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.60 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.30 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.35 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.24 |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.34 |
| Mar 31, 2023 | 0.40 |
| Mar 31, 2022 | 0.40 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.43 |
| Mar 31, 2021 | 0.43 |
| Dec 31, 2020 | 0.45 |
| Sep 30, 2020 | 0.45 |
| Jun 30, 2020 | 0.47 |
| Mar 31, 2020 | 0.49 |
| Dec 31, 2019 | 0.49 |
| Sep 30, 2019 | 0.51 |
| Jun 30, 2019 | 0.51 |
| Mar 31, 2019 | 0.52 |
| Dec 31, 2018 | 0.50 |
| Sep 30, 2018 | 0.51 |
| Jun 30, 2018 | 0.53 |
| Mar 31, 2018 | 0.53 |
| Dec 31, 2017 | 0.53 |
| Sep 30, 2017 | 0.54 |